跳至主要内容
临床试验/NCT02246322
NCT02246322Unknown不适用

A Randomized Clinical Trial With a New Needle Device Comparing 25G and 22G Needle in Endoscopic Ultrasound Fine-needle Aspiration of Solid Lesions.

Istituto Clinico Humanitas2 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2013年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
144
试验地点
2
主要终点
Clinical performance of 22G and 25G needles

研究概览

简要总结

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from the GI wall lesions and from organs adjacent to the GI tract (pancreas, nodes...).Needles available for EUS-FNA include 25G, 22G and 19G. Some studies have suggested that the 25G needle could be equal or even better than the 22G needle.

The BXN system and neddles are is a newly developed for EUS-FNA. This trial is developed for testing the accuracy of the new neddle system for EUS-FNA and for comparing the two needles types, 25G and 22G.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • endosonographic appearance of a solid lesions
  • age >18 years
  • informed consent.

排除标准

  • alteration of the coagulation (INR >1.5, PLT <50 x 103 /µL)
  • inability to express consent

结局指标

主要结局

Clinical performance of 22G and 25G needles

时间窗: 18 months

Evaluation of whether enough material for adequate cytological/histological analysis can obtained with equal efficacy with the 25G and the 22G needles. The percentages of adequate samples obtained.

次要结局

  • Number of crossovers(18 months)
  • Major complications(18 months)
  • Needle malfunction(18 months)
  • Ease of needle pass(18 months)
  • Number of passes(18 months)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Tedeschi

MD

Istituto Clinico Humanitas

研究点 (2)

Loading locations...

相似试验

A Clinical Trial With a New Needle Device Comparing... | 临床试验